Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Baynes Roy D.

Over the trailing 90 days, Baynes Roy D. (Other at Travere Therapeutics, Inc.) traded $613K of stock (net selling $256K) across 3 companies, per 11 SEC Form 4 transactions.

Role
Other
Companies
TVTX NTRA NRIX
Window
Trailing 90 days · 11 transactions · CIK 1680739
Net activity
−$256K ($178K bought · $435K sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
TVTXTravere Therapeutics, Inc.8$178K$435K−$256K
NTRANatera, Inc.2$0
NRIXNurix Therapeutics, Inc.1$0

Transactions (11)

DateSymbolTypeSharesValueDescription
2026-06-26NTRABuy1.6K$0Grant, award or other acquisition
2026-06-26NTRABuy75$0Grant, award or other acquisition
2026-06-12TVTXSell4.5K$225KOpen market or private sale
2026-06-12TVTXSell4.5K$0Exercise or conversion of derivative security
2026-06-12TVTXBuy4.5K$96KExercise or conversion of derivative security
2026-05-19TVTXBuy4.0K$0Grant, award or other acquisition
2026-05-19TVTXBuy12.0K$0Grant, award or other acquisition
2026-05-15NRIXBuy31.2K$0Grant, award or other acquisition
2026-05-05TVTXBuy4.5K$82KExercise or conversion of derivative security
2026-05-05TVTXSell4.5K$210KOpen market or private sale
2026-05-05TVTXSell4.5K$0Exercise or conversion of derivative security

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Baynes's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free